These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 4581503)

  • 1. Non-reactivity of incompatible lymphoid cells from f1 modified radiation chimeras to host tumour cells in vitro.
    Grant CK; Ilbery PL
    Biomedicine; 1973 Feb; 19(2):56-60. PubMed ID: 4581503
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 3. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of a cytophilic factor from challenged immune peritoneal lymphocytes in specific macrophage cytotoxicity.
    Pels E; den Otter W
    Cancer Res; 1974 Nov; 34(11):3089-94. PubMed ID: 4423930
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
    Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of T- and B-cell cooperation in radiation chimeras: evidence for a suppressor effect.
    Gengozian N; Urso P
    Transplant Proc; 1976 Dec; 8(4):631-5. PubMed ID: 793116
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Immunol; 1974 Jun; 112(6):2102-10. PubMed ID: 4825787
    [No Abstract]   [Full Text] [Related]  

  • 9. [Factors affecting the inactivation by lymphocytes of nonsyngeneic stem cells in an irradiated organism].
    Seslavina LS; Khaitov RM
    Radiobiologiia; 1972; 12(4):535-40. PubMed ID: 4571269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI).
    Slavin S; Seidel HJ
    Exp Hematol; 1982 Feb; 10(2):206-16. PubMed ID: 7037437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells.
    Bennett M
    J Immunol; 1973 Feb; 110(2):510-6. PubMed ID: 4405320
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 14. Antidonor immunologic reactions of long-standing radiation chimeras.
    van Bekkum DW; Roodenburg J
    Transplant Proc; 1973 Mar; 5(1):881-6. PubMed ID: 4572150
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential analysis of the virus-immune responder characteristics of thymocytes from F1 leads to parent radiation chimeras.
    Korngold R; Doherty PC
    Thymus; 1982 May; 4(3):119-33. PubMed ID: 6981232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional capacity of cytotoxic lymphoid cells.
    Wunderlich JR; Martin WJ; Macdonald J; Fletcher F
    Natl Cancer Inst Monogr; 1972 Dec; 35():243-9. PubMed ID: 4676543
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure to detect cytotoxic lymphoid cells or humoral blocking factors in mouse radiation chimaeras.
    Grant CK; Leuchars E; Alexander P
    Transplantation; 1972 Dec; 14(6):722-7. PubMed ID: 4566270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.